29 completed, 6 recruiting, 6 unknown, 4 withdrawn. 10 Not applicable, 10 Phase 2, 9 Phase 3, 9 Phase 4, 3 Phase 1.
Follow Hypercalcemia: new trials by email Literature Review of Hypercalcemia trials Research Report on Hypercalcemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The GranStone Trial empagliflozin (Jardiance) 25 mg, Losartan 100 mg - Paraffinoma, Granuloma, Foreign-Body | Phase 2 / Phase 3 | Not yet recruiting | Martin Blomberg Jensen | 100 | 2026-09-01 | 2026-09-18 |
| Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders Osteoporosis, Hypercalcemia | Recruiting | Martin Blomberg Jensen | 20000 | 2026-01-01 | 2026-09-17 | |
| COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable SUBPROTOCOL A, SUBPROTOCOL B, SUBPROTOCOL C - Cardiopulmonary Failure, Myocardial Infarction (MI) | Enrolling by invitation | Peerbridge Health, Inc | 15000 | 2024-11-16 | 2025-01-08 | |
| Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy Parathyroid Eye (PTeye) - Parathyroid Diseases, Parathyroid Dysfunction | Not applicable | Completed | University of California, San Francisco | 79 | 2022-01-10 | 2025-12-15 |
| Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy PTeye, Standard of Care - Parathyroid Adenoma, Parathyroid Neoplasms | Not applicable | Completed | University of Michigan | 160 | 2021-12-01 | 2025-08-27 |
| Familial Hypocalciuric Hypercalcemia: Clinical Aspects and Evolution Observational study. No intervention is performed - Familial Hypocalciuric Hypercalcemia | Completed | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 70 | 2021-02-01 | 2024-04-03 | |
| Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy NIRAF Detection Technology - Parathyroid Adenoma, Parathyroid Neoplasms | Not applicable | Completed | Vanderbilt-Ingram Cancer Center | 160 | 2020-03-13 | 2024-05-13 |
| Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes Parenteral Nutrition (PN) Premixed Olimel N9E - Hyperphosphatemia, Hyperkalemia | Completed | King Faisal Specialist Hospital & Research Center | 72 | 2020-02-02 | 2022-02-03 | |
| Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia CT scan, 24 hour urine collection - Urolithiasis, Renal Colic | Not applicable | Unknown | Ziv Hospital | 150 | 2019-10-01 | 2019-09-25 |
| Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity Calcitonin - Primary Hyperparathyroidism, Hypercalcemia | Phase 4 | Recruiting | Joseph Sferra | 37 | 2019-05-29 | 2024-09-19 |
| Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil Hypercalcemia, Renal Injury | Recruiting | Herlev Hospital | 200 | 2019-04-30 | 2024-10-01 | |
| Hypercalcemia After Paraffin Oil Injection Biochemical observational - Hypercalcemia, Granuloma | Recruiting | Martin Blomberg Jensen | 200 | 2019-04-01 | 2025-04-06 | |
| Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers Vitamin D, Placebo - Asthma, Asthma Exacerbations | Phase 3 | Completed | Professor Francine Ducharme | 323 | 2018-10-01 | 2025-06-03 |
| Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria Rifampin - Idiopathic Infantile Hypercalcaemia - Severe Form, Genetic Disease | Phase 2 | Recruiting | Children's Hospital of Philadelphia | 60 | 2018-07-25 | 2026-10-13 |
| Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland pre operative parathyroid hormone level measurement, pre operative parathyroid cytology, parathyroid hormone level measurement - Parathyroid Adenoma, Hypercalcemia | Not applicable | Withdrawn | HaEmek Medical Center, Israel | 2018-06-09 | 2022-04-11 | |
| The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension - Idiopathic Infantile Hypercalcemia - Mild Form | Phase 1 | Unknown | The Hospital for Sick Children | 5 | 2018-02-22 | 2021-08-31 |
| Registry for Hypoparathyroidism Wuerzburg Comorbidities and Coexisting Conditions, Morality | Recruiting | University of Wuerzburg | 300 | 2017-10-18 | 2022-11-08 | |
| Search for New Genetic Causes of Hypercalcemia by Massively Parallel Sequencing of a Genes Panel genetic analysis with massively parallel sequencing - Hypercalcemia | Completed | University Hospital, Caen | 185 | 2015-12-01 | 2021-08-02 | |
| Insulin Resistance in Primary Hyperparathyroidism parathyroidectomy - Hyperparathyroidism, Diabetes | Not applicable | Withdrawn | Karolinska University Hospital | 2015-10-01 | 2020-09-09 | |
| ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study ACTHAR Gel (adrenocorticotropic hormone) - Sarcoidosis, Hypercalcemia Due to Sarcoidosis | Phase 2 / Phase 3 | Unknown | Albany Medical College | 10 | 2015-02-01 | 2015-01-26 |
Showing 20 of 50. Sign in to see all of them.
Hyperparathyroidism, Primary (13) · Hyperparathyroidism (10) · Hypercalciuria (7) · Parathyroid Neoplasms (7) · Hyperparathyroidism, Secondary (6) · Osteoporosis (6) · Renal Insufficiency, Chronic (5) · Bone Diseases, Metabolic (4) · Nephrocalcinosis (4) · Vitamin D Deficiency (4) · Hyperphosphatemia (3) · Hypocalcemia (3) · Multiple Endocrine Neoplasia (3) · Breast Neoplasms (2)
Calcium Metabolism Disorders (50) · Metabolic Diseases (50) · Nutritional and Metabolic Diseases (50) · Water-Electrolyte Imbalance (50) · Endocrine System Diseases (31) · Parathyroid Diseases (28) · Pathological Conditions, Signs and Symptoms (19) · Hyperparathyroidism (16) · Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Male Urogenital Diseases (13) · Urogenital Diseases (13) · Urologic Diseases (13) · Neoplasms by Site (11) · Pathologic Processes (11)
Cinacalcet (6) · Cholecalciferol (4) · paricalcitol (4) · Vitamin D (3) · Alendronate (2) · Calcitriol (2) · Parathyroidectomy (2) · Rifampin (2) · ARQ 197 (1) · Adrenocorticotropic Hormone (1) · Calcitonin (1) · Calcium Citrate (1) · Denosumab (1) · Ergocalciferols (1) · Genetic Testing (1)
Amgen (3) · Martin Blomberg Jensen (3) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (3) · Columbia University (2) · Abbott (1) · Albany Medical College (1) · Alberta Health services (1) · Children's Hospital of Philadelphia (1) · Chugai Pharma USA (1) · Creighton University (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · HaEmek Medical Center, Israel (1) · Herlev Hospital (1) · Istituto Auxologico Italiano (1) · Josep M Cruzado (1)
United States (23) · Canada (6) · Denmark (5) · Israel (4) · Italy (4) · France (3) · Germany (3) · Poland (3) · Spain (3) · Australia (2) · Belgium (2) · Austria (1) · China (1) · Hungary (1) · India (1)
Shonni J. Silverberg, MD (2) · Smita Jha, M.D. (2) · Carmen C Solorzano, MD, FACS (1) · Daniel W Coyne, MD (1) · Dror Ashkenazi, M.D (1) · Ebbe Eldrup (1) · Efstathios Mitsopoulos, MD (1) · Etienne Sochett, MD (1) · Francine M Ducharme, MD (1) · Haitang Hu, MD (1) · Hakeam Hakeam, MS Pharm (1) · Inga-Lena Nilsson, MD, PhD (1) · J C Gallagher, MD (1) · Jose Pereira, MD (1)
PMID 40668552, PMID 22431675, PMID 23386641, PMID 23990665, PMID 24166866, PMID 24937025, PMID 24970869, PMID 29718393, PMID 30137647, PMID 31215092, PMID 31824976, PMID 35018442, PMID 38027217, PMID 38587077, PMID 40172208, PMID 41966354, PMID 42871976
R01CA212147 (3), 2008 (1), N01CM00039 (1), P30CA016672 (1), R01AG028168 (1), R01DK084986 (1), R01DK112955 (1), U01CA062461 (1)